| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |